top
Search terms
Results 1 - 10 of 19 - ordered by :
Pages: 1 2
Escardio

Genotype-guided oral P2Y12 inhibition reduces bleeding without raising clotting risk in heart attack patients undergoing stent implantation, according to late breaking results from the POPular ...

Date : 03/09/2019
Escardio

Senior author Professor Philippe Gabriel Steg of Hospital Bichat, Paris, France said: “Treatment with ticagrelor and aspirin also increased major bleeding relative to aspirin alone, but there ...

Date : 01/09/2019
Escardio

Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from ...

Date : 27/08/2018
Escardio

Existing antithrombotic therapy during and after PCI consists of the mandatory use of aspirin, intravenous (IV) anticoagulation (such as unfractionated heparin, low molecular weight heparin, or ...

Date : 28/08/2017
Escardio

Formerly considered diuretics, mineralocorticoid receptor antagonists (MRAs) “are still underused in routine clinical practice, but our data may hopefully contribute to expanded use of these ...

Date : 28/08/2017
Escardio

The long-term follow-up of patients in the NIPPON (NoborI dual antiplatelet therapy as aPPrOpriate DuratioN) study is presented today at ESC Congress 2017. “These findings support and ...

Date : 28/08/2017
Escardio

European Society of Cardiology (ESC) Guidelines on the management of acute myocardial infarction in patients with ST-segment elevation are published online today in European Heart Journal, (1) and on ...

Date : 26/08/2017
Escardio

[...]this year’s programme is particularly rich as far as PCI is concerned. Part of our commemorations will include highly educational “Live in the Box” sessions, the ESC Andreas ...

Date : 26/08/2017
Escardio

The antiplatelet drugs prasugrel and ticagrelor had similar safety and efficacy among patients with acute myocardial infarction and ST segment elevations (STEMI), according to results of PRAGUE-18, ...

Date : 30/08/2016
Escardio

Patients with acute coronary syndromes (ACS) who are at high risk for bleeding have significantly lower rates of target lesion revascularisation and fewer adverse events after undergoing percutaneous ...

Date : 17/05/2016